Successful treatment of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation with donor lymphocyte infusion failed to prevent recurrence of primary disease

A case report

S. Cesaro, C. Messina, A. Rosolen, M. C. Putti, L. Sainati, R. Destro, M. V. Gazzola, S. Varotto, G. De Silvestro, G. Scarzello, M. Spinelli, M. Pillon, L. Zanesco

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

We report a case of therapy-related secondary acute myeloid leukemia occurring in a patient during treatment for anaplastic large cell lymphoma. In spite of response to induction chemotherapy and prompt bone marrow transplantation from his matched sister, the patient experienced an early leukemia relapse within 3 months of the transplant. Treatment with oral etoposide for 3 weeks followed by donor lymphocyte infusion achieved a 7-month remission from leukemia without any further treatment. Unfortunately, the patient suffered a recurrence of the primary anaplastic large cell lymphoma that was treated by resuming chemotherapy and local radiotherapy. The patient died 20 months after DLI, still in CR for his leukemia, due to ALCL progression.

Original languageEnglish
Pages (from-to)625-628
Number of pages4
JournalBone Marrow Transplantation
Volume23
Issue number6
Publication statusPublished - 1999

Fingerprint

Homologous Transplantation
Bone Marrow Transplantation
Acute Myeloid Leukemia
Tissue Donors
Lymphocytes
Anaplastic Large-Cell Lymphoma
Recurrence
Leukemia
Induction Chemotherapy
Etoposide
Therapeutics
Siblings
Radiotherapy
Transplants
Drug Therapy

Keywords

  • Allogeneic bone marrow transplantation
  • Anaplastic large cell lymphoma
  • Donor lymphocyte infusion
  • Immunotherapy

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Successful treatment of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation with donor lymphocyte infusion failed to prevent recurrence of primary disease : A case report. / Cesaro, S.; Messina, C.; Rosolen, A.; Putti, M. C.; Sainati, L.; Destro, R.; Gazzola, M. V.; Varotto, S.; De Silvestro, G.; Scarzello, G.; Spinelli, M.; Pillon, M.; Zanesco, L.

In: Bone Marrow Transplantation, Vol. 23, No. 6, 1999, p. 625-628.

Research output: Contribution to journalArticle

Cesaro, S, Messina, C, Rosolen, A, Putti, MC, Sainati, L, Destro, R, Gazzola, MV, Varotto, S, De Silvestro, G, Scarzello, G, Spinelli, M, Pillon, M & Zanesco, L 1999, 'Successful treatment of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation with donor lymphocyte infusion failed to prevent recurrence of primary disease: A case report', Bone Marrow Transplantation, vol. 23, no. 6, pp. 625-628.
Cesaro, S. ; Messina, C. ; Rosolen, A. ; Putti, M. C. ; Sainati, L. ; Destro, R. ; Gazzola, M. V. ; Varotto, S. ; De Silvestro, G. ; Scarzello, G. ; Spinelli, M. ; Pillon, M. ; Zanesco, L. / Successful treatment of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation with donor lymphocyte infusion failed to prevent recurrence of primary disease : A case report. In: Bone Marrow Transplantation. 1999 ; Vol. 23, No. 6. pp. 625-628.
@article{3adf46ebfed14f1884a91c5d24bbf217,
title = "Successful treatment of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation with donor lymphocyte infusion failed to prevent recurrence of primary disease: A case report",
abstract = "We report a case of therapy-related secondary acute myeloid leukemia occurring in a patient during treatment for anaplastic large cell lymphoma. In spite of response to induction chemotherapy and prompt bone marrow transplantation from his matched sister, the patient experienced an early leukemia relapse within 3 months of the transplant. Treatment with oral etoposide for 3 weeks followed by donor lymphocyte infusion achieved a 7-month remission from leukemia without any further treatment. Unfortunately, the patient suffered a recurrence of the primary anaplastic large cell lymphoma that was treated by resuming chemotherapy and local radiotherapy. The patient died 20 months after DLI, still in CR for his leukemia, due to ALCL progression.",
keywords = "Allogeneic bone marrow transplantation, Anaplastic large cell lymphoma, Donor lymphocyte infusion, Immunotherapy",
author = "S. Cesaro and C. Messina and A. Rosolen and Putti, {M. C.} and L. Sainati and R. Destro and Gazzola, {M. V.} and S. Varotto and {De Silvestro}, G. and G. Scarzello and M. Spinelli and M. Pillon and L. Zanesco",
year = "1999",
language = "English",
volume = "23",
pages = "625--628",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Successful treatment of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation with donor lymphocyte infusion failed to prevent recurrence of primary disease

T2 - A case report

AU - Cesaro, S.

AU - Messina, C.

AU - Rosolen, A.

AU - Putti, M. C.

AU - Sainati, L.

AU - Destro, R.

AU - Gazzola, M. V.

AU - Varotto, S.

AU - De Silvestro, G.

AU - Scarzello, G.

AU - Spinelli, M.

AU - Pillon, M.

AU - Zanesco, L.

PY - 1999

Y1 - 1999

N2 - We report a case of therapy-related secondary acute myeloid leukemia occurring in a patient during treatment for anaplastic large cell lymphoma. In spite of response to induction chemotherapy and prompt bone marrow transplantation from his matched sister, the patient experienced an early leukemia relapse within 3 months of the transplant. Treatment with oral etoposide for 3 weeks followed by donor lymphocyte infusion achieved a 7-month remission from leukemia without any further treatment. Unfortunately, the patient suffered a recurrence of the primary anaplastic large cell lymphoma that was treated by resuming chemotherapy and local radiotherapy. The patient died 20 months after DLI, still in CR for his leukemia, due to ALCL progression.

AB - We report a case of therapy-related secondary acute myeloid leukemia occurring in a patient during treatment for anaplastic large cell lymphoma. In spite of response to induction chemotherapy and prompt bone marrow transplantation from his matched sister, the patient experienced an early leukemia relapse within 3 months of the transplant. Treatment with oral etoposide for 3 weeks followed by donor lymphocyte infusion achieved a 7-month remission from leukemia without any further treatment. Unfortunately, the patient suffered a recurrence of the primary anaplastic large cell lymphoma that was treated by resuming chemotherapy and local radiotherapy. The patient died 20 months after DLI, still in CR for his leukemia, due to ALCL progression.

KW - Allogeneic bone marrow transplantation

KW - Anaplastic large cell lymphoma

KW - Donor lymphocyte infusion

KW - Immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=0032982598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032982598&partnerID=8YFLogxK

M3 - Article

VL - 23

SP - 625

EP - 628

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 6

ER -